Galectin Therapeutics Inc (NASDAQ:GALT)

7.67
Delayed Data
As of Jun 22
 -0.04 / -0.52%
Today’s Change
1.28
Today|||52-Week Range
9.49
+129.64%
Year-to-Date

Today’s Trading

Previous close7.71
Today’s open7.65
Day’s range7.51 - 7.97
Volume663,604
Average volume (3 months)681,516
Market cap$151.0M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+35.53%
Earnings growth (this year)-22.45%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.09-9.08%
TRILTrillium Therapeutic...-0.05-0.75%
VRMLVermillion Inc-0.10-10.65%
IDXGInterpace Diagnostic...+0.02+2.28%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$16.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts